Investor Relations

iCo trades on the TSX Venture Exchange under the symbol "ICO", and the OTCQX under the symbol “ICOTF”.

Contacts:

iCo Finance: John Meekison, CFO.  604-602-9414 meekison@icotherapeutics.com

NATIONAL Equicom:Michael Moore, Investor Relations 858-886-7813 mmoore@national.ca

Fact Sheets

Corporate Fact sheet

Oral Delivery System: Amphotericin B Fact sheet

iCo-008 Fact sheet

News Releases

Copyright 2015 ICO Therapeutics | Disclaimer